Tanzania						                            
                            
						
 Case Report
												Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery in a
High-risk Patient: A Case Report 						
Author(s): Annette  Rebel, Anne N  Sloan, Brian  Wetherington, Sean  Dineen and Thomas J  McLarneyAnnette  Rebel, Anne N  Sloan, Brian  Wetherington, Sean  Dineen and Thomas J  McLarney             
						
												
				 Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is an important treatment option for patients with abdominal neoplasms and peritoneal dissemination of disease. However, there are considerable anesthetic risks to the procedure due to the significant temperature fluctuations and fluid shifts. We present a case of a patient with newly diagnosed severe mitral regurgitation who successfully underwent CRS/ HIPEC.
A 64 year old male patient presented to our hospital for evaluation for CRS/HIPEC due to mucinous appendiceal neoplasm with peritoneal dissemination. The preoperative assessment found a severe mitral regurgitation with preserved left ventricular systolic function. The patient was asymptomatic and it was decided to proceed with CRS/ HIPEC. However, the hyperthermia and significant intraoperative fluid shifts associated with a HIPEC proced.. Read More»
				  
												DOI:
												 10.4172/2165-7920.1000963 
																	  
Journal of Clinical Case Reports received 1345 citations as per Google Scholar report